ออฟไลน์ด้วยแอป Player FM !
The COVID Chemistry of a Perfect Match for SpeeDx and SynGenis
Manage episode 319732900 series 3009792
For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned company spun out of Johnson and Johnson that develops PCR testing solutions for infectious diseases including COVID-19. In the wake of the pandemic, SpeeDx faced a constrained supply of oligonucleotides which are a critical component of their diagnostic kits. MTPConnect brokered SpeeDx an introduction to SynGenis and the rest is history in the making!
171 ตอน
Manage episode 319732900 series 3009792
For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned company spun out of Johnson and Johnson that develops PCR testing solutions for infectious diseases including COVID-19. In the wake of the pandemic, SpeeDx faced a constrained supply of oligonucleotides which are a critical component of their diagnostic kits. MTPConnect brokered SpeeDx an introduction to SynGenis and the rest is history in the making!
171 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ